SPDR SP Profile

90.74
USD 1.81  2.04%
55%
13%

SPDR SP Summary

SPDR SP Biotech ETF [XBI] is traded in USA and was established on April 21, 2018. The fund is classified under Sector category within SSgA family. SPDR SP Biotech ETF at this time have 4.96 B in net assets. , while the total return for the last 3 years was 5.66%.
Check SPDR SP Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

SPDR SP Biotech Currency Exposure (%)

 % of ETF 
      Currency 

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 52.51%30 days 90.74  about 47.19%
Based on normal probability distribution, the odds of SPDR SP to move above current price in 30 days from now is about 47.19% (This SPDR SP Biotech ETF probability density function shows the probability of SPDR SP Etf to fall within a particular range of prices over 30 days) .

Top Holders

SPDR SP Biotech Risk Profiles

SPDR SP Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of thirty-nine. SPDR SP Biotech Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe SPDR SP price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Key Fundamentals

SPDR SP Against Markets

Current Ratings

SPDR SP 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 1% 
Equity ratings for SPDR SP Biotech ETF are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. SPDR SP is traded on Archipelago Exchange in USA. more
NameSPDR SP Biotech ETF
Vice PresidentMichael RileyView All
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerSSgA
ExchangeArchipelago Exchange
Etf FamilySSgA
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Contact Number866 787 2257
CurrencyUSD - US Dollar
IssuerSSgA
DescriptionSPDR S&P Biotech ETF
Inception Date2006-01-31
BenchmarkS&P Biotechnology Select Industry TR USD
Entity TypeRegulated Investment Company
Asset Under Management4.96 Billion
Average Trading Valume5.44 Million
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorSSGA Funds Management, Inc.
AdvisorSSgA Funds Management, Inc.
CustodianState Street Bank and Trust Company
DistributorState Street Global Advisors Funds Distributors, LLC
Portfolio ManagerMichael Feehily, Karl Schneider, Raymond Donofrio
Transfer AgentState Street Bank and Trust Company
Fiscal Year EndJune 30
ExchangeNYSE Arca, Inc.
Number of Constituents117
Market MakerVirtu Financial
Total Expense0.35
Management Fee0.35

Diversify with SPDR SP Biotech ETF

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add SPDR SP Biotech ETF to your portfolio
See also Your Current Watchlist. Please also try CEO Directory module to screen ceos from public companies around the world.